GnRH Antagonists in the Treatment of Gynecological and Breast Cancers

Endocrine-Related Cancer - United Kingdom
doi 10.1677/erc.0.0100291
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BioScientifica

Related search

Combination of GHRH Antagonists and Docetaxel Shows Experimental Effectiveness for the Treatment of Triple-Negative Breast Cancers

Oncology Reports
MedicineCancer ResearchOncology
2013English

Disruption of CTCF at the miR-125b1 Locus in Gynecological Cancers and Breast Cancer Cell Lines

Epigenetics and Chromatin
GeneticsMolecular Biology
2013English

Bombesin Antagonists Inhibit Proangiogenic Factors in Human Experimental Breast Cancers

British Journal of Cancer
Cancer ResearchOncology
2004English

Plasma Membrane Expression of GnRH Receptors: Regulation by Antagonists in Breast, Prostate, and Gonadotrope Cell Lines

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2007English

GnRH Antagonists May Affect Endometrial Receptivity

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2008English

Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers

Cancer Research
Cancer ResearchOncology
2007English

Role of Gamma Knife® Radiosurgery for the Treatment of Brain Metastases From Gynecological Cancers

Cureus
2016English

The USE OF GnRH ANTAGONISTS IN OVARIAN STIMULATION FOR INTRAUTERINE INSEMINATION

Turk Jinekoloji ve Obstetrik Dernegi Dergisi
GynecologyObstetrics
2013English

Update on Immune Checkpoint Inhibitors in Gynecological Cancers

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy